Search by Drug Name or NDC

    NDC 69953-0515-01 Morning After 1.5 mg/1.5mg Details

    Morning After 1.5 mg/1.5mg

    Morning After is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Rapha Pharmaceuticals, Inc.. The primary component is LEVONORGESTREL.

    Product Information

    NDC 69953-0515
    Product ID 69953-515_677aa953-3c31-4ce5-e053-2991aa0ab2b2
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Morning After
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levonorgestrel
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 1.5
    Active Ingredient Units mg/1.5mg
    Substance Name LEVONORGESTREL
    Labeler Name Rapha Pharmaceuticals, Inc.
    Pharmaceutical Class Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206867
    Listing Certified Through 2024-12-31

    Package

    NDC 69953-0515-01 (69953051501)

    NDC Package Code 69953-515-01
    Billing NDC 69953051501
    Package 1 BLISTER PACK in 1 CARTON (69953-515-01) / 1 mg in 1 BLISTER PACK
    Marketing Start Date 2018-03-22
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 677aa953-3c30-4ce5-e053-2991aa0ab2b2 Details

    Revised: 3/2018